rs771827120
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_014141.6(CNTNAP2):c.3480_3481delAG(p.Gly1161GlufsTer3) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000248 in 1,613,926 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. T1160T) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_014141.6 frameshift
Scores
Clinical Significance
Conservation
Publications
- complex neurodevelopmental disorderInheritance: AR, AD Classification: DEFINITIVE, NO_KNOWN Submitted by: ClinGen
- cortical dysplasia-focal epilepsy syndromeInheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Illumina, Labcorp Genetics (formerly Invitae), Orphanet, G2P, Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CNTNAP2 | NM_014141.6 | c.3480_3481delAG | p.Gly1161GlufsTer3 | frameshift_variant | Exon 22 of 24 | ENST00000361727.8 | NP_054860.1 | |
LOC105375554 | XR_928093.3 | n.446-1984_446-1983delCT | intron_variant | Intron 4 of 4 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 152042Hom.: 0 Cov.: 33 show subpopulations
GnomAD4 exome AF: 0.00000205 AC: 3AN: 1461884Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 727240 show subpopulations
GnomAD4 genome AF: 0.00000658 AC: 1AN: 152042Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74242 show subpopulations
ClinVar
Submissions by phenotype
Cortical dysplasia-focal epilepsy syndrome Pathogenic:1
This sequence change creates a premature translational stop signal (p.Gly1161Glufs*3) in the CNTNAP2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CNTNAP2 are known to be pathogenic (PMID: 19896112, 21827697, 25045150, 26843181, 27439707). This variant is present in population databases (rs771827120, gnomAD 0.0009%). This premature translational stop signal has been observed in individual(s) with clinical features of CNTNAP2-related conditions (internal data). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 468428). For these reasons, this variant has been classified as Pathogenic. -
Autism, susceptibility to, 15 Pathogenic:1
Variant summary: CNTNAP2 c.3480_3481delAG (p.Gly1161GlufsX3) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The variant was absent in 251442 control chromosomes. To our knowledge, no occurrence of c.3480_3481delAG in individuals affected with Autism, Susceptibility To, 15 and no experimental evidence demonstrating its impact on protein function have been reported. ClinVar contains an entry for this variant (Variation ID: 468428). Based on the evidence outlined above, the variant was classified as pathogenic. -
Autism, susceptibility to, 15;C2750246:Cortical dysplasia-focal epilepsy syndrome Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at